KCG
ONCT

Knight Capital Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Knight Capital Group’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$180K Buy
+20
New +$154K ﹤0.01% 2752

Other funds holding ONCT

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
CII
CR Intrinsic Investors Stamford, Connecticut $2.67B AUM 28.43% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Knight Capital Group's ONCT Position: Q2 2013 in Review

Knight Capital Group opened a new position in Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2013: 20 shares worth $180K. The stake represents ﹤0.01% of the portfolio and ranks #2752 among its holdings.

63 funds tracked by Wall St. Rank hold ONCT as of Q2 2013.

  • Knight Capital Group held 20 shares of Oncternal Therapeutics, Inc. Common Stock worth $180K as of Q2 2013.
  • Oncternal Therapeutics, Inc. Common Stock was a new Knight Capital Group position in Q2 2013.
  • Oncternal Therapeutics, Inc. Common Stock made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2752 holding.
  • 63 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.